Good news for patients with type 2 diabetes: angiotensin receptor blocker treatment delays progression of diabetic nephropathy.
Schiffrin
Ernesto L
EL
Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, Montreal, Quebec, Canada. schiffe@ircm.qc.ca
D057911:Angiotensin Receptor Antagonists; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000503:physiopathology*; D018450:Disease Progression; D006801:Humans
D057911:Angiotensin Receptor Antagonists